Skip header and navigation

Refine By

   MORE

7 records – page 1 of 1.

The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction.

https://arctichealth.org/en/permalink/ahliterature260854
Source
Endocr Pathol. 2014 Jun;25(2):186-92
Publication Type
Article
Date
Jun-2014
Author
G. Rindi
G. Petrone
F. Inzani
Source
Endocr Pathol. 2014 Jun;25(2):186-92
Date
Jun-2014
Language
English
Publication Type
Article
Keywords
Digestive System Neoplasms - classification
Humans
Neoplasm Grading - standards
Neoplasm Staging - standards
Neuroendocrine Tumors - classification
World Health Organization
Abstract
This paper briefly illustrates the basis, rules of application, and present outcome of the current World Health Organization (WHO) classification for neuroendocrine neoplasms. Established in 2010 upon the proposal from the European Neuroendocrine Tumor Society (ENETS), the WHO 2010 fostered some definitional changes (most notably the use of neuroendocrine tumor (NET) instead of carcinoid) and indicated the tools of grading and staging. Specific rules for its application were also defined. The data generated from the use of WHO 2010 classification substantially endorsed its rules and prognostic efficacy. In addition, the application demonstrated some issues, among which are the possible re-definition of the cutoff for grading G1 vs G2, as well as the possible identification of cases with somewhat different clinical behavior within the G3 neuroendocrine cancer class. Overall, since the recent introduction of WHO 2010 grading and staging, it appears wise to keep the current descriptors to avoid unnecessary confusion and to generate comparable data. Homogenous data on large series are ultimately needed to solve such issues.
PubMed ID
24699927 View in PubMed
Less detail

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.

https://arctichealth.org/en/permalink/ahliterature278406
Source
Neuroendocrinology. 2016;103(2):153-71
Publication Type
Conference/Meeting Material
Article
Date
2016
Author
M. Falconi
B. Eriksson
G. Kaltsas
D K Bartsch
J. Capdevila
M. Caplin
B. Kos-Kudla
D. Kwekkeboom
G. Rindi
G. Klöppel
N. Reed
R. Kianmanesh
R T Jensen
Source
Neuroendocrinology. 2016;103(2):153-71
Date
2016
Language
English
Publication Type
Conference/Meeting Material
Article
Keywords
Europe
Humans
Neuroendocrine Tumors - diagnosis - genetics - pathology - therapy
Pancreatic Neoplasms - diagnosis - genetics - pathology - therapy
Notes
Cites: Semin Oncol. 2013 Feb;40(1):37-4423391111
Cites: World J Gastroenterol. 2013 Feb 14;19(6):829-3723430217
Cites: Updates Surg. 2013 Mar;65(1):19-2423417896
Cites: Anticancer Agents Med Chem. 2013 Mar;13(3):382-823092266
Cites: J Nucl Med. 2013 Mar;54(3):364-7223297077
Cites: Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):524-3123224740
Cites: Endocrine. 2013 Apr;43(2):293-30222983831
Cites: N Engl J Med. 2013 Mar 21;368(12):1165-623514309
Cites: Ann Intern Med. 2013 Mar 19;158(6):500-123552360
Cites: Eur J Nucl Med Mol Imaging. 2013 May;40(5):800-1623389427
Cites: Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):705-1723582914
Cites: J Clin Endocrinol Metab. 2013 Dec;98(12):4752-824081736
Cites: Ann Endocrinol (Paris). 2013 Dec;74(5-6):523-3323993836
Cites: J Pediatr Surg. 2013 Dec;48(12):2517-2424314196
Cites: J Surg Res. 2014 Jan;186(1):126-3423992857
Cites: Clin Nucl Med. 2014 Jan;39(1):37-4324152621
Cites: Nat Commun. 2013;4:281024326773
Cites: Pancreas. 2014 Jan;43(1):1-624326362
Cites: Curr Opin Endocrinol Diabetes Obes. 2014 Feb;21(1):3-824310148
Cites: World J Gastroenterol. 2013 Dec 7;19(45):8312-2024363522
Cites: Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):737-5323582916
Cites: Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):791-80223582919
Cites: Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):803-1823582920
Cites: Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):819-3123582921
Cites: Eur J Endocrinol. 2013 May;168(5):665-7423392213
Cites: Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S61-722388623
Cites: PLoS One. 2013;8(4):e6248723614051
Cites: J Clin Oncol. 2013 May 1;31(13):1690-823509317
Cites: Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):897-90723460395
Cites: Medicine (Baltimore). 2013 May;92(3):135-8123645327
Cites: Am J Surg Pathol. 2013 Jun;37(6):853-923598967
Cites: Ann Pharmacother. 2013 Jun;47(6):773-8023632281
Cites: Abdom Imaging. 2013 Jun;38(3):552-6022743840
Cites: J Gastrointest Surg. 2013 Jul;17(7):1224-3223670519
Cites: Eur J Endocrinol. 2013 Jul;169(1):91-723657581
Cites: Expert Rev Anticancer Ther. 2013 Jun;13(6):737-4323573816
Cites: Gastroenterology. 2014 Feb;146(2):453-60.e524148618
Cites: Pancreas. 2014 Mar;43(2):212-824518498
Cites: Curr Med Chem. 2014;21(8):1017-2523992320
Cites: Mol Cell Endocrinol. 2014 Apr 5;386(1-2):2-1523933118
Cites: Neuroendocrinology. 2013;98(4):290-824356648
Cites: Surgery. 2014 Jan;155(1):13-2124238123
Cites: Surgery. 2014 Jan;155(1):145-5324646958
Cites: Pancreas. 2014 May;43(4):526-3124658317
Cites: Ann Surg Oncol. 2015 Mar;22(3):1000-725190116
Cites: Ann Surg. 2015 Aug;262(2):384-825185468
Cites: Q J Nucl Med Mol Imaging. 2016 Mar;60(1):69-7624740163
Cites: Neuroendocrinology. 2016;103(2):144-5226730583
Cites: Neuroendocrinology. 2016;103(2):139-4326730835
Cites: Neuroendocrinology. 2016;103(2):172-8526731013
Cites: Nat Rev Gastroenterol Hepatol. 2012 Apr;9(4):199-20822310917
Cites: Pancreas. 2012 May;41(4):505-722504376
Cites: Pancreas. 2012 May;41(4):547-5322228047
Cites: Clin Chem. 2012 May;58(5):831-622419747
Cites: World J Surg. 2012 Jun;36(6):1375-8122382771
Cites: J Natl Cancer Inst. 2012 May 16;104(10):764-7722525418
Cites: BMJ Case Rep. 2012;2012. pii: bcr1220115327. doi: 10.1136/bcr.12.2011.532722605007
Cites: Int J Clin Pract. 2012 Jun;66(6):582-9122607510
Cites: J Clin Endocrinol Metab. 2012 Jun;97(6):2093-10422442262
Cites: J Gastroenterol. 2012 Jun;47(6):678-8522350698
Cites: Ann Surg Oncol. 2012 Jul;19(7):2295-30322396008
Cites: Eur J Cancer. 2012 Jul;48(11):1608-1522129889
Cites: Pancreas. 2012 Aug;41(6):840-422781907
Cites: Endocrine. 2012 Aug;42(1):80-722350660
Cites: Eur J Endocrinol. 2012 Aug;167(2):181-722581216
Cites: J Clin Oncol. 2008 Jun 20;26(18):3063-7218565894
Cites: Ann Oncol. 2008 Oct;19(10):1727-3318515795
Cites: Cancer. 2008 Oct 1;113(7 Suppl):1807-4318798544
Cites: J Clin Endocrinol Metab. 2009 Mar;94(3):709-2819088155
Cites: Abdom Imaging. 2012 Dec;37(6):1004-2022422069
Cites: Ann Surg. 2013 Feb;257(2):308-1422580937
Cites: ScientificWorldJournal. 2012;2012:35747523304085
Cites: Expert Opin Pharmacother. 2013 Feb;14(3):307-2123363383
Cites: World J Surg. 2013 Mar;37(3):582-9023263686
Cites: Semin Oncol. 2013 Feb;40(1):23-3623391110
Cites: J Clin Endocrinol Metab. 2014 Sep;99(9):3060-924905065
Cites: Pancreas. 2014 Oct;43(7):1003-824945681
Cites: J Nucl Med. 2014 Oct;55(10):1598-60425168627
Cites: Eur J Nucl Med Mol Imaging. 2014 Dec;41(12):2194-20225030618
Cites: Am J Surg. 2014 Nov;208(5):775-8024997491
Cites: Eur J Surg Oncol. 2014 Nov;40(11):1564-7125086992
Cites: Ann Surg Oncol. 2015 Jan;22(1):164-7125190113
Cites: J Gastroenterol. 2015 Jan;50(1):58-6424499825
Cites: Abdom Imaging. 2015 Feb;40(2):299-30925134801
Cites: Br J Surg. 2012 Sep;99(9):1234-4022864882
Cites: Ann Surg. 2012 Sep;256(3):509-1722868363
Cites: Gastrointest Endosc. 2012 Sep;76(3):570-722898415
Cites: Ann Surg Oncol. 2012 Sep;19(9):2932-622350605
Cites: J Clin Endocrinol Metab. 2012 Sep;97(9):2990-301122723327
Cites: J Clin Endocrinol Metab. 2012 Sep;97(9):3039-4522774207
Cites: J Gastroenterol. 2012 Sep;47(9):941-6022886480
Cites: Arch Surg. 2012 Sep;147(9):820-722987171
Cites: Ann Oncol. 2012 Oct;23 Suppl 7:vii124-3022997445
Cites: Endocr J. 2012;59(9):797-80722673601
Cites: World J Gastroenterol. 2012 Oct 21;18(39):5495-50323112541
Cites: Endocr J. 2012;59(10):859-6622785103
Cites: HPB (Oxford). 2012 Dec;14(12):833-823134185
Cites: Surgery. 2012 Dec;152(6):965-7423102679
Cites: Ann Surg Oncol. 2012 Dec;19(13):4270-722752376
Cites: Ann Intern Med. 2012 Dec 4;157(11):767-7523208166
Cites: J Clin Oncol. 2011 Jun 10;29(17):2372-721555696
Cites: Arch Surg. 2011 Jun;146(6):724-3221690450
Cites: Endocrinol Nutr. 2011 Jun-Jul;58(6):258-6621680267
Cites: J Clin Oncol. 2011 Aug 1;29(22):3044-921709192
Cites: Clin Endocrinol (Oxf). 2011 Sep;75(3):277-8421649688
Cites: Endocr Relat Cancer. 2011 Oct;18 Suppl 1:S1-1622005112
Cites: J Clin Endocrinol Metab. 2011 Nov;96(11):3381-921917872
Cites: Surgery. 2011 Dec;150(6):1129-3522136832
Cites: J Magn Reson Imaging. 2000 Feb;11(2):141-810713946
Cites: Medicine (Baltimore). 2001 May;80(3):189-22211388095
Cites: Lancet. 2003 Jan 18;361(9353):228-3012547550
Cites: J Clin Endocrinol Metab. 2003 Mar;88(3):1066-8112629087
Cites: Medicine (Baltimore). 2004 Jan;83(1):43-8314747767
Cites: Eur J Endocrinol. 1997 Jan;136(1):96-99037134
Cites: Gastroenterol Clin Biol. 2004 Nov;28(11):1075-8115657529
Cites: J Gastrointest Surg. 2005 Mar;9(3):381-815749601
Cites: Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):361-516915538
Cites: Medicine (Baltimore). 2006 Nov;85(6):295-33017108778
Cites: Medicine (Baltimore). 2006 Nov;85(6):331-6417108779
Cites: Endocr Relat Cancer. 2006 Dec;13(4):1195-20217158764
Cites: Neuroendocrinology. 2006;84(3):173-8217312377
Cites: Ann Surg Oncol. 2007 Jul;14(7):2121-717431724
Cites: J Mol Neurosci. 2007;33(3):225-3117952631
Cites: Endocr Relat Cancer. 2008 Mar;15(1):229-4118310290
Cites: Am J Surg Pathol. 2008 Mar;32(3):420-518300808
Cites: World J Surg. 2008 May;32(5):904-1718264824
Cites: J Clin Oncol. 2008 May 1;26(13):2124-3018445841
Cites: Best Pract Res Clin Gastroenterol. 2013 Jun;27(3):443-5423998981
Cites: Curr Opin Gastroenterol. 2013 Nov;29(6):650-6124100728
Cites: Surg Today. 2013 Nov;43(11):1281-522983734
Cites: JAMA Surg. 2013 Oct;148(10):932-923986355
Cites: Neuroendocrinology. 2013;98(2):156-6823988576
Cites: Radiol Med. 2013 Oct;118(7):1082-10123801403
Cites: J Endocrinol Invest. 2013 Oct;36(9):753-823608735
Cites: Best Pract Res Clin Endocrinol Metab. 2013 Dec;27(6):763-924275188
Cites: Pancreatology. 2013 Nov-Dec;13(6):589-9324280574
Cites: Adv Surg. 2013;47:59-7924298844
Cites: Clin Endocrinol (Oxf). 2014 Jan;80(1):80-423711285
Cites: J Clin Endocrinol Metab. 2013 Dec;98(12):4784-924057286
Cites: Pancreas. 2011 Mar;40(2):213-2121178652
Cites: Pancreas. 2011 Mar;40(2):308-1021311308
Cites: Hum Pathol. 2011 Mar;42(3):324-3121190722
Cites: Mod Pathol. 2011 Mar;24(3):412-2420890270
Cites: Science. 2011 Mar 4;331(6021):1199-20321252315
Cites: Cancer. 2011 Apr 1;117(7):1377-8521425137
Cites: World J Gastroenterol. 2011 Mar 14;17(10):1343-5321455335
Cites: Clin Endocrinol (Oxf). 2011 May;74(5):593-821470282
Cites: Gastroenterology. 2011 May;140(5):1444-5321315717
Cites: Curr Treat Options Oncol. 2011 Jun;12(2):136-4821437592
Cites: J Clin Oncol. 2011 Jun 10;29(17):2416-2321555692
Cites: Surgery. 2011 Dec;150(6):1143-5222136834
Cites: J Endocrinol Invest. 2011 Oct;34(9):e253-821623151
Cites: Clin Gastroenterol Hepatol. 2012 Feb;10(2):126-3021806955
Cites: Clin Gastroenterol Hepatol. 2012 Feb;10(2):199-20221871248
Cites: Clin Nucl Med. 2012 Mar;37(3):245-5122310250
Cites: Dig Liver Dis. 2012 Mar;44(3):228-3422078814
Cites: Exp Clin Endocrinol Diabetes. 2012 Feb;120(2):68-7222187292
Cites: Neuroendocrinology. 2012;95(2):120-3422261872
Cites: Neuroendocrinology. 2012;95(2):98-11922261919
Cites: Neuroendocrinology. 2012;95(2):157-7622262022
Cites: Drugs. 2012 Mar 5;72(4):437-4522356286
Cites: Eur J Gastroenterol Hepatol. 2012 Apr;24(4):368-7422410712
Cites: J Clin Endocrinol Metab. 2009 May;94(5):1826-3419141585
Cites: Pancreas. 2013 Aug;42(6):903-423851427
Cites: Pancreas. 2013 Aug;42(6):932-623851430
Cites: Ann Endocrinol (Paris). 2013 Jul;74(3):174-8423790314
Cites: Ann Endocrinol (Paris). 2013 Jul;74(3):196-923791453
Cites: Expert Opin Drug Saf. 2013 Sep;12(5):709-1623808631
Cites: Clin Transl Oncol. 2013 Sep;15(9):725-3123460559
Cites: World J Gastroenterol. 2013 Dec 21;19(47):9012-924379626
Cites: J Clin Endocrinol Metab. 2014 Jan;99(1):E89-9624178797
Cites: Ann Surg. 2014 Feb;259(2):197-20324253141
Cites: Cancer Med. 2013 Oct;2(5):701-1124403235
Cites: Neuroendocrinology. 2016;103(2):186-9426731334
Cites: Neuroendocrinology. 2016;103(2):125-3826758972
Cites: Neuroendocrinology. 2016;103(2):119-2426784901
Cites: World J Surg. 2009 Jun;33(6):1197-20719294466
Cites: Neuroendocrinology. 2009;90(2):184-919713709
Cites: Eur Radiol. 2009 Oct;19(10):2467-7319597822
Cites: J Clin Endocrinol Metab. 2009 Nov;94(11):4398-40519820010
Cites: World J Surg. 2010 Feb;34(2):249-5519949948
Cites: Endocr Relat Cancer. 2010 Mar;17(1):R53-7319995807
Cites: Clin Cancer Res. 2010 Feb 1;16(3):978-8520103666
Cites: J Clin Oncol. 2010 Apr 1;28(10):1652-920194865
Cites: J Nucl Med. 2010 May;51(5):669-7320395323
Cites: Mod Pathol. 2010 Jun;23(6):824-3320305616
Cites: Pancreas. 2010 Aug;39(6):735-5220664472
Cites: Ann Surg Oncol. 2010 Sep;17(9):2427-4320217257
Cites: Gastroenterology. 2010 Sep;139(3):742-53, 753.e120637207
Cites: Intern Med. 2010;49(19):2123-720930440
Cites: Ann Surg. 2010 Nov;252(5):850-621037441
Cites: Curr Gastroenterol Rep. 2010 Dec;12(6):448-5720882439
Cites: Dig Dis Sci. 2011 Jan;56(1):139-5420725788
Cites: Hepatogastroenterology. 2013 Nov-Dec;60(128):2099-10224719954
Cites: Int J Cancer. 2014 Jul 1;135(1):128-3724347111
Cites: Biomark Med. 2014;8(4):571-8024796622
Cites: J Clin Endocrinol Metab. 2014 May;99(5):1519-2424512490
Cites: World J Gastroenterol. 2014 May 7;20(17):4908-1624803802
Cites: J Clin Endocrinol Metab. 2014 Mar;99(3):748-5624285676
Cites: Pancreas. 2014 Jul;43(5):675-8624921202
Cites: Endocr Pathol. 2014 Jun;25(2):186-9224699927
Cites: Int J Surg. 2014;12 Suppl 1:S152-524862672
Cites: BMC Endocr Disord. 2014;14:6425099181
PubMed ID
26742109 View in PubMed
Less detail

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

https://arctichealth.org/en/permalink/ahliterature175208
Source
Neuroendocrinology. 2004;80(6):394-424
Publication Type
Conference/Meeting Material
Article
Date
2004
Author
U. Plöckinger
G. Rindi
R. Arnold
B. Eriksson
E P Krenning
W W de Herder
A. Goede
M. Caplin
K. Oberg
J C Reubi
O. Nilsson
G. Delle Fave
P. Ruszniewski
H. Ahlman
B. Wiedenmann
Author Affiliation
Department of Hepatology and Gastroenterology, Interdisciplinary Center for Metabolism, Endocrinology, and Diabetes, Charité-Universitatsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany. ursula.ploeckinger@charite.de
Source
Neuroendocrinology. 2004;80(6):394-424
Date
2004
Language
English
Publication Type
Conference/Meeting Material
Article
Keywords
Gastrointestinal Neoplasms - diagnosis - therapy
Humans
Neuroendocrine Tumors - diagnosis - therapy
PubMed ID
15838182 View in PubMed
Less detail

[The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas: comment].

https://arctichealth.org/en/permalink/ahliterature141104
Source
Pathologe. 2010 Sep;31(5):353-4
Publication Type
Article
Date
Sep-2010
Author
G. Klöppel
G. Rindi
A. Perren
P. Komminoth
D S Klimstra
Author Affiliation
Konsultationszentrum für Pankreas und Endokrine Tumoren, Institut für Pathologie, Technische Universität München, Ismaningerstr. 22, 81675, München, Deutschland. guenter.kloeppel@alumni.uni-kiel.de
Source
Pathologe. 2010 Sep;31(5):353-4
Date
Sep-2010
Language
German
Publication Type
Article
Keywords
Carcinoid Tumor - classification - pathology
Consensus
Gastrointestinal Neoplasms - classification - pathology
Humans
Neoplasm Invasiveness - pathology
Neoplasm Staging - methods
Neuroendocrine Tumors - classification - pathology
Pancreatic Neoplasms - classification - pathology
Prognosis
Societies, Medical
Notes
Comment On: Pathologe. 2010 Sep;31(5):348-5220798945
PubMed ID
20809402 View in PubMed
Less detail

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

https://arctichealth.org/en/permalink/ahliterature167548
Source
Virchows Arch. 2006 Oct;449(4):395-401
Publication Type
Conference/Meeting Material
Article
Date
Oct-2006
Author
G. Rindi
G. Klöppel
H. Alhman
M. Caplin
A. Couvelard
W W de Herder
B. Erikssson
A. Falchetti
M. Falconi
P. Komminoth
M. Körner
J M Lopes
A-M McNicol
O. Nilsson
A. Perren
A. Scarpa
J-Y Scoazec
B. Wiedenmann
Author Affiliation
Dipartimento di Patologia e, Medicina di Laboratorio, Sezione di Anatomia Patologica, Università di Parma, Via Gramsci, 14, 43100, Parma, Italy, and Department of Internal Medicine, Royal Free Hospital, London, UK. guido.rindi@unipr.it
Source
Virchows Arch. 2006 Oct;449(4):395-401
Date
Oct-2006
Language
English
Publication Type
Conference/Meeting Material
Article
Keywords
Digestive System Neoplasms - chemistry - classification - diagnosis
Humans
Lymph Nodes - chemistry - pathology
Mitotic Index
Neoplasm Metastasis - diagnosis
Neoplasm Staging - methods - standards
Neuroendocrine Tumors - chemistry - classification - diagnosis
Tumor Markers, Biological - analysis
Abstract
The need for standards in the management of patients with endocrine tumors of the digestive system prompted the European Neuroendocrine Tumor Society (ENETS) to organize a first Consensus Conference, which was held in Frascati (Rome) and was based on the recently published ENETS guidelines on the diagnosis and treatment of digestive neuroendocrine tumors (NET). Here, we report the tumor-node-metastasis proposal for foregut NETs of the stomach, duodenum, and pancreas that was designed, discussed, and consensually approved at this conference. In addition, we report the proposal for a working formulation for the grading of digestive NETs based on mitotic count and Ki-67 index. This proposal, which needs to be validated, is meant to help clinicians in the stratification, treatment, and follow-up of patients.
Notes
Cites: Digestion. 2000;62 Suppl 1:19-2610940683
Cites: Ann Oncol. 2006 Mar;17(3):461-616364959
Cites: Cancer. 2001 Oct 15;92(8):2204-1011596039
Cites: Int J Cancer. 2001 Nov 1;94(3):444-811745428
Cites: J Clin Oncol. 2002 Jun 1;20(11):2633-4212039924
Cites: Hum Pathol. 2002 Nov;33(11):1126-3212454818
Cites: Cancer. 2003 Feb 15;97(4):934-5912569593
Cites: Ann Oncol. 2004 Jun;15(6):966-7315151956
Cites: Ann Surg. 2004 Jul;240(1):117-2215213627
Cites: Digestion. 1988;41(4):185-2003072229
Cites: Hum Pathol. 1996 Nov;27(11):1124-348912819
Cites: J Clin Oncol. 1998 Mar;16(3):1040-539508189
Cites: Am J Gastroenterol. 1998 Mar;93(3):422-89517651
Cites: Gastroenterology. 1999 Mar;116(3):532-4210029611
Cites: Acta Oncol. 2004;43(7):617-2515545182
Cites: Acta Oncol. 2004;43(7):626-3615545183
Cites: Neuroendocrinology. 2004;80(4):244-5115627802
Cites: Am J Surg Pathol. 2005 Apr;29(4):524-3315767809
Cites: Gastroenterology. 2005 May;128(5):1187-9815887103
Cites: Gastroenterology. 2005 May;128(6):1717-5115887161
Cites: Gut. 2005 Jun;54 Suppl 4:iv1-1615888809
Cites: Neuroendocrinology. 2004;80(6):394-42415838182
Cites: Ann Oncol. 2005 Aug;16(8):1374-8015939719
Cites: Endocr Relat Cancer. 2005 Dec;12(4):1083-9216322345
Cites: Anticancer Res. 2005 Nov-Dec;25(6C):4463-916334127
Cites: Cancer Res. 2001 Jan 1;61(1):285-9211196176
PubMed ID
16967267 View in PubMed
Less detail

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

https://arctichealth.org/en/permalink/ahliterature162101
Source
Virchows Arch. 2007 Oct;451(4):757-62
Publication Type
Conference/Meeting Material
Article
Date
Oct-2007
Author
G. Rindi
G. Klöppel
A. Couvelard
P. Komminoth
M. Körner
J M Lopes
A-M McNicol
O. Nilsson
A. Perren
A. Scarpa
J-Y Scoazec
B. Wiedenmann
Author Affiliation
Department of Pathology, University of Parma, Parma, Italy. guido.rindi@unipr.it
Source
Virchows Arch. 2007 Oct;451(4):757-62
Date
Oct-2007
Language
English
Publication Type
Conference/Meeting Material
Article
Keywords
Appendiceal Neoplasms - diagnosis - pathology
Carcinoma, Neuroendocrine - diagnosis - pathology
Cell Proliferation
Colonic Neoplasms - diagnosis - pathology
Europe
Guidelines as Topic
Humans
Ileal Neoplasms - diagnosis - pathology
Lymph Nodes - pathology
Lymphatic Metastasis
Neoplasm Staging - methods
Rectal Neoplasms - diagnosis - pathology
Abstract
Criteria for the staging and grading of neuroendocrine tumors (NETs) of midgut and hindgut origin were established at the second Consensus Conference in Frascati (Rome) organized by the European Neuroendocrine Tumor Society (ENETS). The proposed tumor-node-metastasis (TNM) classifications are based on the recently published ENETS Guidelines for the Diagnosis and Treatment of gastroenteropancreatic NETs and follow our previous proposal for foregut tumors. The new TNM classifications for NETs of the ileum, appendix, colon, and rectum, and the grading system were designed, discussed, and consensually approved by all conference participants. These proposals need to be validated and are meant to help clinicians in the stratification, treatment and follow-up of patients.
PubMed ID
17674042 View in PubMed
Less detail

TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.

https://arctichealth.org/en/permalink/ahliterature125020
Source
J Natl Cancer Inst. 2012 May 16;104(10):764-77
Publication Type
Article
Date
May-16-2012
Author
G. Rindi
M. Falconi
C. Klersy
L. Albarello
L. Boninsegna
M W Buchler
C. Capella
M. Caplin
A. Couvelard
C. Doglioni
G. Delle Fave
L. Fischer
G. Fusai
W W de Herder
H. Jann
P. Komminoth
R R de Krijger
S. La Rosa
T V Luong
U. Pape
A. Perren
P. Ruszniewski
A. Scarpa
A. Schmitt
E. Solcia
B. Wiedenmann
Author Affiliation
Institute of Anatomic Pathology, Università Cattolica del Sacro Cuore, Histopathology and Cytodiagnosis Unit, Policlinico Gemelli, Largo A. Gemelli, 8, Roma I-00168, Italy. guido.rindi@rm.unicatt.it
Source
J Natl Cancer Inst. 2012 May 16;104(10):764-77
Date
May-16-2012
Language
English
Publication Type
Article
Keywords
Adult
Age Distribution
Aged
Cohort Studies
Confounding Factors (Epidemiology)
Europe - epidemiology
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Multivariate Analysis
Neoplasm Staging
Neuroendocrine Tumors - epidemiology - mortality - pathology
Observer Variation
Odds Ratio
Pancreatic Neoplasms - epidemiology - mortality - pathology
Predictive value of tests
Proportional Hazards Models
Retrospective Studies
Sex Distribution
United States - epidemiology
Abstract
Both the European Neuroendocrine Tumor Society (ENETS) and the International Union for Cancer Control/American Joint Cancer Committee/World Health Organization (UICC/AJCC/WHO) have proposed TNM staging systems for pancreatic neuroendocrine neoplasms. This study aims to identify the most accurate and useful TNM system for pancreatic neuroendocrine neoplasms.
The study included 1072 patients who had undergone previous surgery for their cancer and for which at least 2 years of follow-up from 1990 to 2007 was available. Data on 28 variables were collected, and the performance of the two TNM staging systems was compared by Cox regression analysis and multivariable analyses. All statistical tests were two-sided.
Differences in distribution of sex and age were observed for the ENETS TNM staging system. At Cox regression analysis, only the ENETS TNM staging system perfectly allocated patients into four statistically significantly different and equally populated risk groups (with stage I as the reference; stage II hazard ratio [HR] of death = 16.23, 95% confidence interval [CI] = 2.14 to 123, P = .007; stage III HR of death = 51.81, 95% CI = 7.11 to 377, P
PubMed ID
22525418 View in PubMed
Less detail

7 records – page 1 of 1.